Directed share issue and private placement in Zealand Pharma A/S (DK) – DKK 1.5 billion

Carnegie acted as financial adviser in the directed share issue and private placement of 3,761,470 new shares in Zealand Pharma A/S, representing approximately 6.4% of Zealand’s currently registered share capital. The transaction was structured as a PIPE directed towards two reputable institutional shareholders. Zealand will receive gross proceeds of approximately DKK 1.5bn from the private placement. The net proceeds from the private placement are expected to be used to further strengthen Zealand’s investment in its differentiated assets targeting obesity.

Read more